Rakesh N Veedu
Rakesh N Veedu
Associate Professor at Murdoch University & Perron Institute
Verified email at - Homepage
Cited by
Cited by
Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics
D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ...
Theranostics 10 (8), 3684, 2020
Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
T Wang, C Chen, LM Larcher, RA Barrero, RN Veedu
Biotechnology advances 37 (1), 28-50, 2019
Locked nucleic acids: promising nucleic acid analogs for therapeutic applications
RN Veedu, J Wengel
Chemistry & biodiversity 7 (3), 536-542, 2010
Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides
T Wang, LM Larcher, L Ma, RN Veedu
Molecules 23 (10), 2564, 2018
Locked nucleic acid as a novel class of therapeutic agents
RN Veedu, J Wengel
RNA biology 6 (3), 321-323, 2009
In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies
F Lipi, S Chen, M Chakravarthy, S Rakesh, RN Veedu
RNA biology 13 (12), 1232-1245, 2016
Recent advances in oligonucleotide therapeutics in oncology
H Xiong, RN Veedu, SD Diermeier
International Journal of Molecular Sciences 22 (7), 3295, 2021
G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold
M Marušič, RN Veedu, J Wengel, J Plavec
Nucleic Acids Research 41 (20), 9524-9536, 2013
Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics
GR Kokil, RN Veedu, GA Ramm, JB Prins, HS Parekh
Chemical Reviews 115 (11), 4719-4743, 2015
Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates
RN Veedu, B Vester, J Wengel
Journal of the American Chemical Society 130 (26), 8124-8125, 2008
Enzymatic incorporation of LNA nucleotides into DNA strands
RN Veedu, B Vester, J Wengel
ChemBioChem 8 (5), 490-492, 2007
Antisense oligonucleotides targeting angiogenic factors as potential cancer therapeutics
BT Le, P Raguraman, TR Kosbar, S Fletcher, SD Wilton, RN Veedu
Molecular Therapy-Nucleic Acids 14, 142-157, 2019
Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers
S Dawar, N Singh, RK Kanwar, RL Kennedy, RN Veedu, SF Zhou, ...
Drug Discovery Today 18 (23-24), 1292-1300, 2013
Enzymatic recognition of 2′‐modified ribonucleoside 5′‐triphosphates: Towards the evolution of versatile aptamers
LH Lauridsen, JA Rothnagel, RN Veedu
ChemBioChem 13 (1), 19-25, 2012
Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase
RN Veedu, B Vester, J Wengel
Organic & biomolecular chemistry 7 (7), 1404-1409, 2009
Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers
RN Veedu, J Wengel
Molecular BioSystems 5 (8), 787-792, 2009
Rapid one-step selection method for generating nucleic acid aptamers: Development of a DNA aptamer against α-bungarotoxin
LH Lauridsen, HA Shamaileh, SL Edwards, E Taran, RN Veedu
Public Library of Science 7 (7), e41702, 2012
Nucleic acid-based aptamers: applications, development and clinical trials
J R Kanwar, K Roy, N G Maremanda, K Subramanian, R N Veedu, ...
Current Medicinal Chemistry 22 (21), 2539-2557, 2015
Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis
T Wang, L Chen, A Chikkanna, S Chen, I Brusius, N Sbuh, RN Veedu
Theranostics 11 (11), 5174, 2021
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition
SL Edwards, V Poongavanam, JR Kanwar, K Roy, KM Hillman, N Prasad, ...
Chemical Communications 51 (46), 9499-9502, 2015
The system can't perform the operation now. Try again later.
Articles 1–20